期刊文献+

血清胱抑素C水平与帕金森病进展关系的研究 被引量:1

Association of cystatin C levels with H&Y scale and duration of pakinson's disease
原文传递
导出
摘要 目的 研究帕金森病(PD)患者血清胱抑素C(CC)水平的变化,及其与H&Y评分、PD患病时间之间的关系.方法 收集PD患者(PD组)432例,健康体检者(对照组)513例,根据H&Y评分将PD组分为3个亚组,分别检测CC浓度及Scr浓度,进行统计学分析.结果 PD组与对照组CC浓度比较差异有统计学意义(P<0.05),Scr浓度在两组中差异无统计学意义(P>0.05).PD组各亚组中,中期组CC浓度高于早期组及对照组(P<0.05),晚期组CC浓度明显高于对照组及其他两个亚组(P<0.05),秩相关分析对比CC浓度与PD患病时间呈正相关(r=0.209,P<0.01),CC浓度与H&Y评分呈正相关(r=0.618,P<0.01).结论 CC水平与PD有一定相关性,PD患者的CC水平明显增高.在疾病初始阶段升高不明显,也许CC不一定是PD发病的原因,但其水平与H&Y评分及患病时间呈正相关,CC可能参与疾病进展的过程,高水平的CC可能会加重PD患者病情. Objective To investigate the levels of cystatin C (CC) with the H&Y scale and duration of Pakinson's disease(PD)patients.Methods The study consists of 432 PD patients and 513 control subjects.PD patients were divided into 3 subgroups according to their H&Y scale.The levels of CC and Scr were measured.The statistics analysis was used to evaluate their associations.Results In PD and control groups, CC concentrations were significantly different (P 〈 0.05), and Scr concentrations in two study groups were not significantly different(P 〉 0.05).PD in each subgroup, CC concentrations in the medium group were significantly higher than the early and control groups, and CC in the late group was significantly higher than the other two subgroups.Rank correlation analysis and comparison of CC concentration and duration and H&Y score showed that CC concentration was positively correlated with the duration of PD(r =0.209, P 〈0.01), and that CC concentration and H&Y score were significantly positively correlated (r =0.618, P 〈0.01).Conclusions There was a certain correlation between CC levels and PD, and CC levels of PD patients were significantly higher.There was no significant increased CC in the initial stages of the disease, perhaps CC was not necessary cause of the onset of PD.However, the level of CC with H&Y stage and duration were positively correlated, perhaps CC may be involved in the process of disease progression, because high level of CC may increase PD patient's condition.
作者 王娜 冯娟
出处 《中国医师杂志》 CAS 2015年第11期1690-1693,共4页 Journal of Chinese Physician
关键词 半胱氨酸蛋白酶抑制剂/代谢 帕金森病/代谢 Cysteine proteinase inhibitors/ME Parkinson disease/ME
  • 相关文献

参考文献17

  • 1Gallegos S, Pacheco C, Peters C, et al. Features of alpha-synu- clein that could explain the progression and irreversibility of Par- kinson's disease[ J]. Front Neurosci, 2015,9:59.
  • 2魏旺丽(综述),李萃,詹显全(审校).DJ-1基因的研究进展[J].中国医师杂志,2013,15(11):1579-1581. 被引量:2
  • 3Shadrina MI, Slominsky PA, Limborska SA. Molecular mecha- nisms of pathogenesis of Parkinson' s disease [J]. Int Rev Cell Mol Biol, 2010,281:229-266.
  • 4Gauthier S, Kaur G, Mi W, et al. Protective mechanisms by cys- tatin C in neurodegenerative diseases [J]. Front Biosci ( Schol Ed) ,2011,3:541-554.
  • 5Kaur G, Levy E. Cystatin C in Alzheimer's disease [J]. Front Mol Neurosci, 2012,5:79.
  • 6Ghidoni R, Benussi L, Glionna M, et al. Plasma cystatin C and risk of developing Alzheimer's disease in subjects with mild cogni- tive impairment[J]. J Alzheimers Dis, 2010,22(3) :985-991.
  • 7Wilson ME, Boumaza I, Lacomis D, et al. Cystatin C: a candi-date biomarker for amyotrophic lateral sclerosis [J]. PLoS One, 2010,5(12) :e15133.
  • 8Yamamoto-Watanabe Y, Watanabe M, Jackson M, et al. Quanti- fication of cystatin C in cerebrospinal fluid from various neurologi- cal disorders and correlation with G73A polymorphism in CST3 F .17. Brain Res. 2010.1361 : 140-145.
  • 9Tizon B, Sahoo S, Yu H, et al. Induction of autophagy by cystatin C: a mechanism that protects murine primary cortical neurons and neuronal cell lines [ J ]. PLoS One,2010,5 (3) : e9819.
  • 10Danielson SR, Andersen JK. Oxidative and nitrative protein modi- fications in Parkinson's disease [ J ]. Free Radic Biol Med, 2008, 44(10) :1787-1794.

二级参考文献26

  • 1Hao LY, Giasson BI, Bonini NM. DJ-1 is critical for mitochondri- al function and rescues PINK1 loss of function. Proc Natl Acad Sci U S A, 2010, 107(21 ) :9747-9752.
  • 2Corti O, Lesage S, Brice A. What genetics tells us about the cau- ses and mechanisms of Parkinsons disease. Physiol Rev, 2011, 91(4):1161.
  • 3Guo JF, Xiao B, Liao B, et al. Mutation analysis of Parkin, PINK1, DJ-I and ATP13A2 genes in Chinese patients with auto- somal recessive early-onset Parkinsonism. Mov Disord, 2008, 23 (14) :2074-2079.
  • 4Sadhukhan T, Biswas A, Das SK, et al. D J-1 variants in Indian Parkinson's disease patients. Dis Markers, 2012, 33 (3):127- 135.
  • 5Lee JY, Song J, Kwan K, et al. Human D J-1 and its homologs an novel glyoxalases. Hum Mol Genet, 2012, 21 (14) :3215-3225.
  • 6Le HT, Gautier V, Kthiri l7, et al. YajL, prokaryotie homolog of parkinsonism-associated protein D J-l, functions as a eovalent chaperone for thiol proteome. J Biol Chem, 2012, 287(8) :5861- 5870.
  • 7Deeg S, Gralle M, Sroka K, et al. BAG1 restores formation of functional DJ-1 L166P dimers and DJ-1 chaperone activity. J Cell Biol, 2010, 188(4) :505-513.
  • 8Shen GM, Dou W, Huang Y, et al. In silico cloning and annota- tion of genes involved in the digestion, detoxification and RNA in- terference mechanism in the midgut of Bactrocera dorsalis [ I-Iendel (Diptera: Tephritidae). Insect Mol Biol, 2013, 22(4): 354- 365.
  • 9Zhang Y, Liu G, Lin C, et al. Silencing the EZH2 gene by RNA interference reverses the drug resistance of hmnan hepatic multi- drug-resistant cancer cells to 5-Fu. Life Sci, 2013, 92(17-19) : 896-902.
  • 10He X, Zheng Z, Li J, et al. DJ-1 promotes invasion and metas- tasis of pancreatic cancer cells by activating SRC/ERK/uPA. Carcinogenesis, 2012, 33 (3) :555-62.

共引文献1

同被引文献3

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部